Trajenta® (linagliptin
Type 2 Diabetes
There are two main types of diabetes: Type 1 and Type 2. Type 2 Diabetes is the most common: 9 out of 10 people who have diabetes will have Type 2 Diabetes. It usually starts after the age of 40, but it can affect younger people as well. It is a condition that comes from both your genes and lifestyle.1,2
Type 2 Diabetes tends to develop gradually (over weeks or months). This is because in Type 2 Diabetes you still make insulin (unlike in Type 1 Diabetes). If you have Type 2 Diabetes this leads to high levels of glucose (sugar) in your blood.
Type 2 Diabetes can be caused by:
- The pancreas not making enough insulin to control blood sugar levels
- The cells in the body being less able to respond to insulin (called insulin resistance)
- a combination of both
This results in high levels of glucose in your blood which can lead to long-term medical problems like heart disease, stroke, kidney disease, blindness and poor circulation in your limbs. If you have Type 2 Diabetes it is important to keep your blood glucose levels as close to normal as possible and to have a healthy lifestyle, to reduce this risk.
References
-
Type 2 diabetes Available at: https://www.diabetes.org.uk/type-2-diabetes (accessed November 2024)
-
Preventing type 2 diabetes and risk factors. Available at: https://www.diabetes.org.uk/preventing-type-2-diabetes/diabetes-risk-factors (accessed November 2024)
Where can I find more information?
Patient Information Leaflet
The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Patient Information Leaflet (UK)
Summary of Product Characteristics
The Summary of Product Characteristics tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the opinion of a healthcare professional.
Summary of Product Characteristics (UK)
NP-GB-105211 V2 | December 2024